http://142-54-23-223.fusionmedialtd.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 06 Jul 2026 16:05:34 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://142-54-23-223.fusionmedialtd.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Board+Changes/Kalaris+Therapeutics+names+Laurie+Keating+to+its+board/26735422.html <p>Kalaris Therapeutics, Inc. (Nasdaq: KLRS) announced the appointment of Laurie Keating to its board of directors, effective August 1, 2026, according to a press release. Concurrently, board member Morana Jovan-Embiricos is stepping down.</p> <p>Keating currently serves as chair of the board of PepGen (Nasdaq: PEPG) and as a board member of Immuneering Corp (Nasdaq: IMRX). She previously served on the boards of Imago Biosciences, which was acquired by Merck, Imbria Pharmaceuticals, and the Massachusetts Biotechnology Council.</p> <p>Keating formerly held the role of Executive Vice President, General Counsel and Corporate Secretary at Alnylam Pharmaceuticals, where she oversaw global government affairs, legal, intellectual property, http://www.streetinsider.com/Board+Changes/Kalaris+Therapeutics+names+Laurie+Keating+to+its+board/26735422.html Mon, 06 Jul 2026 16:05:34 -0400 A.03295816 A.18418130 A.33519386 A.50114195 A.50204695 IMRX KLRS O.00168533 O.00172988 O.05887791 O.20558987 O.46370305 O.65181662 PEPG http://www.streetinsider.com/Board+Changes/Kalaris+Therapeutics+names+Laurie+Keating+to+its+board/26735422.html <p>Kalaris Therapeutics, Inc. (Nasdaq: KLRS) announced the appointment of Laurie Keating to its board of directors, effective August 1, 2026, according to a press release. Concurrently, board member Morana Jovan-Embiricos is stepping down.</p> <p>Keating currently serves as chair of the board of PepGen (Nasdaq: PEPG) and as a board member of Immuneering Corp (Nasdaq: IMRX). She previously served on the boards of Imago Biosciences, which was acquired by Merck, Imbria Pharmaceuticals, and the Massachusetts Biotechnology Council.</p> <p>Keating formerly held the role of Executive Vice President, General Counsel and Corporate Secretary at Alnylam Pharmaceuticals, where she oversaw global government affairs, legal, intellectual property, http://www.streetinsider.com/Board+Changes/Kalaris+Therapeutics+names+Laurie+Keating+to+its+board/26735422.html Mon, 06 Jul 2026 16:05:34 -0400 A.03295816 A.18418130 A.33519386 A.50114195 A.50204695 IMRX KLRS O.00168533 O.00172988 O.05887791 O.20558987 O.46370305 O.65181662 PEPG http://www.streetinsider.com/Board+Changes/Kalaris+Therapeutics+names+Laurie+Keating+to+its+board/26735422.html <p>Kalaris Therapeutics, Inc. (Nasdaq: KLRS) announced the appointment of Laurie Keating to its board of directors, effective August 1, 2026, according to a press release. Concurrently, board member Morana Jovan-Embiricos is stepping down.</p> <p>Keating currently serves as chair of the board of PepGen (Nasdaq: PEPG) and as a board member of Immuneering Corp (Nasdaq: IMRX). She previously served on the boards of Imago Biosciences, which was acquired by Merck, Imbria Pharmaceuticals, and the Massachusetts Biotechnology Council.</p> <p>Keating formerly held the role of Executive Vice President, General Counsel and Corporate Secretary at Alnylam Pharmaceuticals, where she oversaw global government affairs, legal, intellectual property, http://www.streetinsider.com/Board+Changes/Kalaris+Therapeutics+names+Laurie+Keating+to+its+board/26735422.html Mon, 06 Jul 2026 16:05:34 -0400 A.03295816 A.18418130 A.33519386 A.50114195 A.50204695 IMRX KLRS O.00168533 O.00172988 O.05887791 O.20558987 O.46370305 O.65181662 PEPG http://www.streetinsider.com/Board+Changes/Kalaris+Therapeutics+names+Laurie+Keating+to+its+board/26735422.html <p>Kalaris Therapeutics, Inc. (Nasdaq: KLRS) announced the appointment of Laurie Keating to its board of directors, effective August 1, 2026, according to a press release. Concurrently, board member Morana Jovan-Embiricos is stepping down.</p> <p>Keating currently serves as chair of the board of PepGen (Nasdaq: PEPG) and as a board member of Immuneering Corp (Nasdaq: IMRX). She previously served on the boards of Imago Biosciences, which was acquired by Merck, Imbria Pharmaceuticals, and the Massachusetts Biotechnology Council.</p> <p>Keating formerly held the role of Executive Vice President, General Counsel and Corporate Secretary at Alnylam Pharmaceuticals, where she oversaw global government affairs, legal, intellectual property, http://www.streetinsider.com/Board+Changes/Kalaris+Therapeutics+names+Laurie+Keating+to+its+board/26735422.html Mon, 06 Jul 2026 16:05:34 -0400 A.03295816 A.18418130 A.33519386 A.50114195 A.50204695 IMRX KLRS O.00168533 O.00172988 O.05887791 O.20558987 O.46370305 O.65181662 PEPG http://www.streetinsider.com/Board+Changes/Kalaris+Therapeutics+names+Laurie+Keating+to+its+board/26735422.html <p>Kalaris Therapeutics, Inc. (Nasdaq: KLRS) announced the appointment of Laurie Keating to its board of directors, effective August 1, 2026, according to a press release. Concurrently, board member Morana Jovan-Embiricos is stepping down.</p> <p>Keating currently serves as chair of the board of PepGen (Nasdaq: PEPG) and as a board member of Immuneering Corp (Nasdaq: IMRX). She previously served on the boards of Imago Biosciences, which was acquired by Merck, Imbria Pharmaceuticals, and the Massachusetts Biotechnology Council.</p> <p>Keating formerly held the role of Executive Vice President, General Counsel and Corporate Secretary at Alnylam Pharmaceuticals, where she oversaw global government affairs, legal, intellectual property, http://www.streetinsider.com/Board+Changes/Kalaris+Therapeutics+names+Laurie+Keating+to+its+board/26735422.html Mon, 06 Jul 2026 16:05:34 -0400 A.03295816 A.18418130 A.33519386 A.50114195 A.50204695 IMRX KLRS O.00168533 O.00172988 O.05887791 O.20558987 O.46370305 O.65181662 PEPG http://www.streetinsider.com/Board+Changes/Kalaris+Therapeutics+names+Laurie+Keating+to+its+board/26735422.html <p>Kalaris Therapeutics, Inc. (Nasdaq: KLRS) announced the appointment of Laurie Keating to its board of directors, effective August 1, 2026, according to a press release. Concurrently, board member Morana Jovan-Embiricos is stepping down.</p> <p>Keating currently serves as chair of the board of PepGen (Nasdaq: PEPG) and as a board member of Immuneering Corp (Nasdaq: IMRX). She previously served on the boards of Imago Biosciences, which was acquired by Merck, Imbria Pharmaceuticals, and the Massachusetts Biotechnology Council.</p> <p>Keating formerly held the role of Executive Vice President, General Counsel and Corporate Secretary at Alnylam Pharmaceuticals, where she oversaw global government affairs, legal, intellectual property, http://www.streetinsider.com/Board+Changes/Kalaris+Therapeutics+names+Laurie+Keating+to+its+board/26735422.html Mon, 06 Jul 2026 16:05:34 -0400 A.03295816 A.18418130 A.33519386 A.50114195 A.50204695 IMRX KLRS O.00168533 O.00172988 O.05887791 O.20558987 O.46370305 O.65181662 PEPG http://www.streetinsider.com/Board+Changes/Kalaris+Therapeutics+names+Laurie+Keating+to+its+board/26735422.html <p>Kalaris Therapeutics, Inc. (Nasdaq: KLRS) announced the appointment of Laurie Keating to its board of directors, effective August 1, 2026, according to a press release. Concurrently, board member Morana Jovan-Embiricos is stepping down.</p> <p>Keating currently serves as chair of the board of PepGen (Nasdaq: PEPG) and as a board member of Immuneering Corp (Nasdaq: IMRX). She previously served on the boards of Imago Biosciences, which was acquired by Merck, Imbria Pharmaceuticals, and the Massachusetts Biotechnology Council.</p> <p>Keating formerly held the role of Executive Vice President, General Counsel and Corporate Secretary at Alnylam Pharmaceuticals, where she oversaw global government affairs, legal, intellectual property, http://www.streetinsider.com/Board+Changes/Kalaris+Therapeutics+names+Laurie+Keating+to+its+board/26735422.html Mon, 06 Jul 2026 16:05:34 -0400 A.03295816 A.18418130 A.33519386 A.50114195 A.50204695 IMRX KLRS O.00168533 O.00172988 O.05887791 O.20558987 O.46370305 O.65181662 PEPG http://www.streetinsider.com/Board+Changes/Kalaris+Therapeutics+names+Laurie+Keating+to+its+board/26735422.html <p>Kalaris Therapeutics, Inc. (Nasdaq: KLRS) announced the appointment of Laurie Keating to its board of directors, effective August 1, 2026, according to a press release. Concurrently, board member Morana Jovan-Embiricos is stepping down.</p> <p>Keating currently serves as chair of the board of PepGen (Nasdaq: PEPG) and as a board member of Immuneering Corp (Nasdaq: IMRX). She previously served on the boards of Imago Biosciences, which was acquired by Merck, Imbria Pharmaceuticals, and the Massachusetts Biotechnology Council.</p> <p>Keating formerly held the role of Executive Vice President, General Counsel and Corporate Secretary at Alnylam Pharmaceuticals, where she oversaw global government affairs, legal, intellectual property, http://www.streetinsider.com/Board+Changes/Kalaris+Therapeutics+names+Laurie+Keating+to+its+board/26735422.html Mon, 06 Jul 2026 16:05:34 -0400 A.03295816 A.18418130 A.33519386 A.50114195 A.50204695 IMRX KLRS O.00168533 O.00172988 O.05887791 O.20558987 O.46370305 O.65181662 PEPG http://www.streetinsider.com/Board+Changes/Kalaris+Therapeutics+names+Laurie+Keating+to+its+board/26735422.html <p>Kalaris Therapeutics, Inc. (Nasdaq: KLRS) announced the appointment of Laurie Keating to its board of directors, effective August 1, 2026, according to a press release. Concurrently, board member Morana Jovan-Embiricos is stepping down.</p> <p>Keating currently serves as chair of the board of PepGen (Nasdaq: PEPG) and as a board member of Immuneering Corp (Nasdaq: IMRX). She previously served on the boards of Imago Biosciences, which was acquired by Merck, Imbria Pharmaceuticals, and the Massachusetts Biotechnology Council.</p> <p>Keating formerly held the role of Executive Vice President, General Counsel and Corporate Secretary at Alnylam Pharmaceuticals, where she oversaw global government affairs, legal, intellectual property, http://www.streetinsider.com/Board+Changes/Kalaris+Therapeutics+names+Laurie+Keating+to+its+board/26735422.html Mon, 06 Jul 2026 16:05:34 -0400 A.03295816 A.18418130 A.33519386 A.50114195 A.50204695 IMRX KLRS O.00168533 O.00172988 O.05887791 O.20558987 O.46370305 O.65181662 PEPG http://www.streetinsider.com/Board+Changes/Kalaris+Therapeutics+names+Laurie+Keating+to+its+board/26735422.html <p>Kalaris Therapeutics, Inc. (Nasdaq: KLRS) announced the appointment of Laurie Keating to its board of directors, effective August 1, 2026, according to a press release. Concurrently, board member Morana Jovan-Embiricos is stepping down.</p> <p>Keating currently serves as chair of the board of PepGen (Nasdaq: PEPG) and as a board member of Immuneering Corp (Nasdaq: IMRX). She previously served on the boards of Imago Biosciences, which was acquired by Merck, Imbria Pharmaceuticals, and the Massachusetts Biotechnology Council.</p> <p>Keating formerly held the role of Executive Vice President, General Counsel and Corporate Secretary at Alnylam Pharmaceuticals, where she oversaw global government affairs, legal, intellectual property, http://www.streetinsider.com/Board+Changes/Kalaris+Therapeutics+names+Laurie+Keating+to+its+board/26735422.html Mon, 06 Jul 2026 16:05:34 -0400 A.03295816 A.18418130 A.33519386 A.50114195 A.50204695 IMRX KLRS O.00168533 O.00172988 O.05887791 O.20558987 O.46370305 O.65181662 PEPG http://www.streetinsider.com/Board+Changes/Kalaris+Therapeutics+names+Laurie+Keating+to+its+board/26735422.html <p>Kalaris Therapeutics, Inc. (Nasdaq: KLRS) announced the appointment of Laurie Keating to its board of directors, effective August 1, 2026, according to a press release. Concurrently, board member Morana Jovan-Embiricos is stepping down.</p> <p>Keating currently serves as chair of the board of PepGen (Nasdaq: PEPG) and as a board member of Immuneering Corp (Nasdaq: IMRX). She previously served on the boards of Imago Biosciences, which was acquired by Merck, Imbria Pharmaceuticals, and the Massachusetts Biotechnology Council.</p> <p>Keating formerly held the role of Executive Vice President, General Counsel and Corporate Secretary at Alnylam Pharmaceuticals, where she oversaw global government affairs, legal, intellectual property, http://www.streetinsider.com/Board+Changes/Kalaris+Therapeutics+names+Laurie+Keating+to+its+board/26735422.html Mon, 06 Jul 2026 16:05:34 -0400 A.03295816 A.18418130 A.33519386 A.50114195 A.50204695 IMRX KLRS O.00168533 O.00172988 O.05887791 O.20558987 O.46370305 O.65181662 PEPG http://www.streetinsider.com/Board+Changes/Kalaris+Therapeutics+names+Laurie+Keating+to+its+board/26735422.html <p>Kalaris Therapeutics, Inc. (Nasdaq: KLRS) announced the appointment of Laurie Keating to its board of directors, effective August 1, 2026, according to a press release. Concurrently, board member Morana Jovan-Embiricos is stepping down.</p> <p>Keating currently serves as chair of the board of PepGen (Nasdaq: PEPG) and as a board member of Immuneering Corp (Nasdaq: IMRX). She previously served on the boards of Imago Biosciences, which was acquired by Merck, Imbria Pharmaceuticals, and the Massachusetts Biotechnology Council.</p> <p>Keating formerly held the role of Executive Vice President, General Counsel and Corporate Secretary at Alnylam Pharmaceuticals, where she oversaw global government affairs, legal, intellectual property, http://www.streetinsider.com/Board+Changes/Kalaris+Therapeutics+names+Laurie+Keating+to+its+board/26735422.html Mon, 06 Jul 2026 16:05:34 -0400 A.03295816 A.18418130 A.33519386 A.50114195 A.50204695 IMRX KLRS O.00168533 O.00172988 O.05887791 O.20558987 O.46370305 O.65181662 PEPG http://www.streetinsider.com/Board+Changes/Kalaris+Therapeutics+names+Laurie+Keating+to+its+board/26735422.html <p>Kalaris Therapeutics, Inc. (Nasdaq: KLRS) announced the appointment of Laurie Keating to its board of directors, effective August 1, 2026, according to a press release. Concurrently, board member Morana Jovan-Embiricos is stepping down.</p> <p>Keating currently serves as chair of the board of PepGen (Nasdaq: PEPG) and as a board member of Immuneering Corp (Nasdaq: IMRX). She previously served on the boards of Imago Biosciences, which was acquired by Merck, Imbria Pharmaceuticals, and the Massachusetts Biotechnology Council.</p> <p>Keating formerly held the role of Executive Vice President, General Counsel and Corporate Secretary at Alnylam Pharmaceuticals, where she oversaw global government affairs, legal, intellectual property, http://www.streetinsider.com/Board+Changes/Kalaris+Therapeutics+names+Laurie+Keating+to+its+board/26735422.html Mon, 06 Jul 2026 16:05:34 -0400 A.03295816 A.18418130 A.33519386 A.50114195 A.50204695 IMRX KLRS O.00168533 O.00172988 O.05887791 O.20558987 O.46370305 O.65181662 PEPG http://www.streetinsider.com/Board+Changes/Kalaris+Therapeutics+names+Laurie+Keating+to+its+board/26735422.html <p>Kalaris Therapeutics, Inc. (Nasdaq: KLRS) announced the appointment of Laurie Keating to its board of directors, effective August 1, 2026, according to a press release. Concurrently, board member Morana Jovan-Embiricos is stepping down.</p> <p>Keating currently serves as chair of the board of PepGen (Nasdaq: PEPG) and as a board member of Immuneering Corp (Nasdaq: IMRX). She previously served on the boards of Imago Biosciences, which was acquired by Merck, Imbria Pharmaceuticals, and the Massachusetts Biotechnology Council.</p> <p>Keating formerly held the role of Executive Vice President, General Counsel and Corporate Secretary at Alnylam Pharmaceuticals, where she oversaw global government affairs, legal, intellectual property, http://www.streetinsider.com/Board+Changes/Kalaris+Therapeutics+names+Laurie+Keating+to+its+board/26735422.html Mon, 06 Jul 2026 16:05:34 -0400 A.03295816 A.18418130 A.33519386 A.50114195 A.50204695 IMRX KLRS O.00168533 O.00172988 O.05887791 O.20558987 O.46370305 O.65181662 PEPG http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PepGen+Inc.+++++++++++++++For%3A+Jun+18++Filed+by%3A+Shah+Rajeev+M./26673589.html si-local-file:///var/storage/secattach/20260622/26673589.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PepGen+Inc.+++++++++++++++For%3A+Jun+18++Filed+by%3A+Shah+Rajeev+M./26673589.html Mon, 22 Jun 2026 16:32:00 -0400 O.50075559 PEPG http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PepGen+Inc.+++++++++++++++For%3A+Jun+18++Filed+by%3A+Shah+Rajeev+M./26673589.html si-local-file:///var/storage/secattach/20260622/26673589.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PepGen+Inc.+++++++++++++++For%3A+Jun+18++Filed+by%3A+Shah+Rajeev+M./26673589.html Mon, 22 Jun 2026 16:32:00 -0400 O.50075559 PEPG http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++PepGen+Inc.+++++++++++++++For%3A+Jun+18/26673524.html si-local-file:///var/storage/secattach/20260622/26673524.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++PepGen+Inc.+++++++++++++++For%3A+Jun+18/26673524.html Mon, 22 Jun 2026 16:30:00 -0400 O.50075559 PEPG http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++PepGen+Inc.+++++++++++++++For%3A+Jun+18/26673524.html si-local-file:///var/storage/secattach/20260622/26673524.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++PepGen+Inc.+++++++++++++++For%3A+Jun+18/26673524.html Mon, 22 Jun 2026 16:30:00 -0400 O.50075559 PEPG http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PepGen+Inc.+++++++++++++++For%3A+Jun+18++Filed+by%3A+Wyman+Lisa/26673225.html si-local-file:///var/storage/secattach/20260622/26673225.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PepGen+Inc.+++++++++++++++For%3A+Jun+18++Filed+by%3A+Wyman+Lisa/26673225.html Mon, 22 Jun 2026 16:14:00 -0400 O.50075559 PEPG http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PepGen+Inc.+++++++++++++++For%3A+Jun+18++Filed+by%3A+Wyman+Lisa/26673225.html si-local-file:///var/storage/secattach/20260622/26673225.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PepGen+Inc.+++++++++++++++For%3A+Jun+18++Filed+by%3A+Wyman+Lisa/26673225.html Mon, 22 Jun 2026 16:14:00 -0400 O.50075559 PEPG http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PepGen+Inc.+++++++++++++++For%3A+Jun+18++Filed+by%3A+Resnick+Joshua/26673173.html si-local-file:///var/storage/secattach/20260622/26673173.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PepGen+Inc.+++++++++++++++For%3A+Jun+18++Filed+by%3A+Resnick+Joshua/26673173.html Mon, 22 Jun 2026 16:13:00 -0400 O.50075559 PEPG http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PepGen+Inc.+++++++++++++++For%3A+Jun+18++Filed+by%3A+Resnick+Joshua/26673173.html si-local-file:///var/storage/secattach/20260622/26673173.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PepGen+Inc.+++++++++++++++For%3A+Jun+18++Filed+by%3A+Resnick+Joshua/26673173.html Mon, 22 Jun 2026 16:13:00 -0400 O.50075559 PEPG http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PepGen+Inc.+++++++++++++++For%3A+Jun+18++Filed+by%3A+Mayer+Howard/26673108.html si-local-file:///var/storage/secattach/20260622/26673108.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PepGen+Inc.+++++++++++++++For%3A+Jun+18++Filed+by%3A+Mayer+Howard/26673108.html Mon, 22 Jun 2026 16:11:00 -0400 O.50075559 PEPG http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PepGen+Inc.+++++++++++++++For%3A+Jun+18++Filed+by%3A+Mayer+Howard/26673108.html si-local-file:///var/storage/secattach/20260622/26673108.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PepGen+Inc.+++++++++++++++For%3A+Jun+18++Filed+by%3A+Mayer+Howard/26673108.html Mon, 22 Jun 2026 16:11:00 -0400 O.50075559 PEPG http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PepGen+Inc.+++++++++++++++For%3A+Jun+18++Filed+by%3A+Finer+Mitchell+H./26673060.html si-local-file:///var/storage/secattach/20260622/26673060.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PepGen+Inc.+++++++++++++++For%3A+Jun+18++Filed+by%3A+Finer+Mitchell+H./26673060.html Mon, 22 Jun 2026 16:08:00 -0400 O.50075559 PEPG